Parnell Pharmaceuticals Holdings Ltd (PARN) to Release Earnings on Wednesday
Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) is scheduled to be posting its quarterly earnings results on Wednesday, October 19th.
Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) opened at 1.48 on Tuesday. The stock’s 50 day moving average is $1.48 and its 200-day moving average is $1.67. Parnell Pharmaceuticals Holdings Ltd has a 1-year low of $1.34 and a 1-year high of $4.89. The firm’s market cap is $21.72 million.
An institutional investor recently raised its position in Parnell Pharmaceuticals Holdings stock. BlackRock Group LTD boosted its stake in shares of Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) by 2.5% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 217,196 shares of the company’s stock after buying an additional 5,200 shares during the period. BlackRock Group LTD owned 1.64% of Parnell Pharmaceuticals Holdings worth $354,000 as of its most recent SEC filing.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/18/parnell-pharmaceuticals-holdings-ltd-parn-to-release-earnings-on-wednesday.html
Parnell Pharmaceuticals Holdings Company Profile
Parnell Pharmaceuticals Holdings Limited is a veterinary pharmaceutical company. The Company is focused on developing, manufacturing and commercializing animal health solutions. The principal activities of the Company include manufacture for global sale of animal pharmaceutical product, and research and development of pharmaceutical products for global animal health markets.
Receive News & Ratings for Parnell Pharmaceuticals Holdings Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parnell Pharmaceuticals Holdings Ltd and related companies with MarketBeat.com's FREE daily email newsletter.